Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV

Genvoya first TAF-based regimen approved in China for adults and adolescents with HIV
-  China National Drug Administration (CNDA) has approved Genvoya(elvitegravir 150mg/cobicistat 150mg/emtricitabine 200mg/tenofovir ...